NTI164 in Autism Spectrum Disorder
NTI164 in Autism Spectrum Disorder
Not yet recruiting · NCT07257939 · Registry updated 2026-09-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| NTI164 in Autism Spectrum Disorder | Chemically-Induced Disorders, autism, autism spectrum disorder, cannabis dependence, neurodevelopmental disorder, pervasive developmental disorder, psychiatric disorder, substance-related disorder | Not yet recruiting | Phase 3 | 2026-09-30 | NCT07257939 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fenix Innovation Group | 2 |
| Neurotech International Limited | 2 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Children's Hospital Queensland | Brisbane | Australia | 1 |
| Monash Health | Clayton | Australia | 74 |
| Sunshine Coast University Hospital | Sunshine Coast | Australia | 2 |